Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Pont

Showing results (91-100 of 131) with videos related to

Pageof 14
Sort By:
Journal of the National Cancer Institute|January 6, 2000
Hematologic disorders associated with primary mediastinal nonseminomatous germ cell tumorsJ T Hartmann, C R Nichols, J P Droz, et al.
Gastroenterologia Y Hepatologia|November 17, 2004
[Recurrent ingestion of foreign bodies and abdominal self-injury as a form of attempted suicide]J I Rodríguez Hermosa, J Roig García, B Ruiz Feliú, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 17, 2001
Second-line chemotherapy in patients with relapsed extragonadal nonseminomatous germ cell tumors: results of an international multicenter analysisJ T Hartmann, L Einhorn, C R Nichols, et al.
Annals of Hematology|December 24, 1997
Randomized open label phase III trial of CEOP/IMVP-Dexa alternating chemotherapy and filgrastim versus CEOP/IMVP-Dexa alternating chemotherapy for aggressive non-Hodgkin's lymphoma (NHL). A multicenter trial by the Austrian Working Group for Medical Tumor TherapyM A Fridrik, R Greil, H Hausmaninger, et al.
Cancer|April 3, 2001
Extragonadal seminoma: an international multicenter analysis of prognostic factors and long term treatment outcomeC Bokemeyer, J P Droz, A Horwich, et al.
Blood|May 23, 2022
NOTCH1 signaling during CD4+ T-cell activation alters transcription factor networks and enhances antigen responsivenessAlec B Wilkens, Elena C Fulton, Margot J Pont, et al.
Journal of the National Cancer Institute|November 22, 2001
Incidence of metachronous testicular cancer in patients with extragonadal germ cell tumorsJ T Hartmann, S D Fossa, C R Nichols, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1996
CEOP-IMVP-Dexa in the treatment of aggressive lymphomas: an Austrian multicenter trialM A Fridrik, H Hausmaninger, W Linkesch, et al.
Blood|October 7, 2024
Single-cell analysis of the multiple myeloma microenvironment after γ-secretase inhibition and CAR T-cell therapyDavid G Coffey, Pinar Ataca Atilla, Erden Atilla, et al.
Contemporary Clinical Trials|August 27, 2019
Design and participant characteristics of TX sprouts: A school-based cluster randomized gardening, nutrition, and cooking interventionJaimieN Davis, Katie Nikah, Fiona M Asigbee, et al.
Pageof 14

Showing results (91-100 of 131) with videos related to

Sort By:
Pageof 14
Journal of the National Cancer Institute|January 6, 2000
Hematologic disorders associated with primary mediastinal nonseminomatous germ cell tumorsJ T Hartmann, C R Nichols, J P Droz, et al.
Gastroenterologia Y Hepatologia|November 17, 2004
[Recurrent ingestion of foreign bodies and abdominal self-injury as a form of attempted suicide]J I Rodríguez Hermosa, J Roig García, B Ruiz Feliú, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 17, 2001
Second-line chemotherapy in patients with relapsed extragonadal nonseminomatous germ cell tumors: results of an international multicenter analysisJ T Hartmann, L Einhorn, C R Nichols, et al.
Annals of Hematology|December 24, 1997
Randomized open label phase III trial of CEOP/IMVP-Dexa alternating chemotherapy and filgrastim versus CEOP/IMVP-Dexa alternating chemotherapy for aggressive non-Hodgkin's lymphoma (NHL). A multicenter trial by the Austrian Working Group for Medical Tumor TherapyM A Fridrik, R Greil, H Hausmaninger, et al.
Cancer|April 3, 2001
Extragonadal seminoma: an international multicenter analysis of prognostic factors and long term treatment outcomeC Bokemeyer, J P Droz, A Horwich, et al.
Blood|May 23, 2022
NOTCH1 signaling during CD4+ T-cell activation alters transcription factor networks and enhances antigen responsivenessAlec B Wilkens, Elena C Fulton, Margot J Pont, et al.
Journal of the National Cancer Institute|November 22, 2001
Incidence of metachronous testicular cancer in patients with extragonadal germ cell tumorsJ T Hartmann, S D Fossa, C R Nichols, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1996
CEOP-IMVP-Dexa in the treatment of aggressive lymphomas: an Austrian multicenter trialM A Fridrik, H Hausmaninger, W Linkesch, et al.
Blood|October 7, 2024
Single-cell analysis of the multiple myeloma microenvironment after γ-secretase inhibition and CAR T-cell therapyDavid G Coffey, Pinar Ataca Atilla, Erden Atilla, et al.
Contemporary Clinical Trials|August 27, 2019
Design and participant characteristics of TX sprouts: A school-based cluster randomized gardening, nutrition, and cooking interventionJaimieN Davis, Katie Nikah, Fiona M Asigbee, et al.
Pageof 14